Short Term Palmitate Supply Impairs Intestinal Insulin Signaling via Ceramide Production

The worldwide prevalence of metabolic diseases is increasing, and there are global recommendations to limit consumption of certain nutrients, especially saturated lipids. Insulin resistance, a common trait occurring in obesity and type 2 diabetes, is associated with intestinal lipoprotein overproduc...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Journal of biological chemistry Jg. 291; H. 31; S. 16328
Hauptverfasser: Tran, Thi Thu Trang, Postal, Bárbara Graziela, Demignot, Sylvie, Ribeiro, Agnès, Osinski, Céline, Pais de Barros, Jean-Paul, Blachnio-Zabielska, Agnieszka, Leturque, Armelle, Rousset, Monique, Ferré, Pascal, Hajduch, Eric, Carrière, Véronique
Format: Journal Article
Sprache:Englisch
Veröffentlicht: United States 29.07.2016
Schlagworte:
Animals
Caco-2 Cells
Ceramides - biosynthesis
Enterocytes - metabolism
Humans
Insulin - metabolism
Intestinal Mucosa - metabolism
Mice
Palm Oil
Palmitic Acid - metabolism
Palmitic Acid - pharmacology
Phosphorylation - drug effects
Plant Oils - pharmacology
Proto-Oncogene Proteins c-akt - metabolism
Signal Transduction
ceramide
intestine
signaling
insulin
fatty acid
Akt PKB
lipid
palmitic acid
ISSN:1083-351X, 1083-351X
Online-Zugang:Weitere Angaben
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The worldwide prevalence of metabolic diseases is increasing, and there are global recommendations to limit consumption of certain nutrients, especially saturated lipids. Insulin resistance, a common trait occurring in obesity and type 2 diabetes, is associated with intestinal lipoprotein overproduction. However, the mechanisms by which the intestine develops insulin resistance in response to lipid overload remain unknown. Here, we show that insulin inhibits triglyceride secretion and intestinal microsomal triglyceride transfer protein expression in vivo in healthy mice force-fed monounsaturated fatty acid-rich olive oil but not in mice force-fed saturated fatty acid-rich palm oil. Moreover, when mouse intestine and human Caco-2/TC7 enterocytes were treated with the saturated fatty acid, palmitic acid, the insulin-signaling pathway was impaired. We show that palmitic acid or palm oil increases ceramide production in intestinal cells and that treatment with a ceramide analogue partially reproduces the effects of palmitic acid on insulin signaling. In Caco-2/TC7 enterocytes, ceramide effects on insulin-dependent AKT phosphorylation are mediated by protein kinase C but not by protein phosphatase 2A. Finally, inhibiting de novo ceramide synthesis improves the response of palmitic acid-treated Caco-2/TC7 enterocytes to insulin. These results demonstrate that a palmitic acid-ceramide pathway accounts for impaired intestinal insulin sensitivity, which occurs within several hours following initial lipid exposure.
Bibliographie:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1083-351X
1083-351X
DOI:10.1074/jbc.M115.709626